Crescita Therapeutics Statistics

Total Valuation

TSX:CTX has a market cap or net worth of CAD 10.83 million. The enterprise value is 2.39 million.

Market Cap	10.83M
Enterprise Value	2.39M

Important Dates

The next estimated earnings date is Thursday, May 8, 2025.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

TSX:CTX has 19.01 million shares outstanding. The number of shares has decreased by -4.44% in one year.

Current Share Class	n/a
Shares Outstanding	19.01M
Shares Change (YoY)	-4.44%
Shares Change (QoQ)	-0.78%
Owned by Insiders (%)	12.99%
Owned by Institutions (%)	0.79%
Float	16.54M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.55
PB Ratio	0.68
P/TBV Ratio	0.77
P/FCF Ratio	17.25
P/OCF Ratio	3.98
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.87
EV / Sales	0.12
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	3.81

Financial Position

The company has a current ratio of 2.77, with a Debt / Equity ratio of 0.05.

Current Ratio	2.77
Quick Ratio	1.99
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	1.33
Interest Coverage	-47.51

Financial Efficiency

Return on equity (ROE) is -15.87% and return on invested capital (ROIC) is -10.51%.

Return on Equity (ROE)	-15.87%
Return on Assets (ROA)	-8.32%
Return on Invested Capital (ROIC)	-10.51%
Return on Capital Employed (ROCE)	-18.99%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.84
Inventory Turnover	1.96

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +29.55% in the last 52 weeks. The beta is 1.48, so TSX:CTX's price volatility has been higher than the market average.

Beta (5Y)	1.48
52-Week Price Change	+29.55%
50-Day Moving Average	0.56
200-Day Moving Average	0.58
Relative Strength Index (RSI)	52.76
Average Volume (20 Days)	21,420

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSX:CTX had revenue of CAD 19.58 million and -2.75 million in losses. Loss per share was -0.14.

Revenue	19.58M
Gross Profit	9.61M
Operating Income	-3.09M
Pretax Income	-2.76M
Net Income	-2.75M
EBITDA	-2.15M
EBIT	-3.09M
Loss Per Share	-0.14

Full Income Statement

Balance Sheet

The company has 9.28 million in cash and 834,000 in debt, giving a net cash position of 8.44 million or 0.44 per share.

Cash & Cash Equivalents	9.28M
Total Debt	834,000
Net Cash	8.44M
Net Cash Per Share	0.44
Equity (Book Value)	15.83M
Book Value Per Share	0.83
Working Capital	9.79M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.73 million and capital expenditures -2.10 million, giving a free cash flow of 628,000.

Operating Cash Flow	2.73M
Capital Expenditures	-2.10M
Free Cash Flow	628,000
FCF Per Share	0.03

Full Cash Flow Statement

Margins

Gross margin is 49.07%, with operating and profit margins of -15.77% and -14.04%.

Gross Margin	49.07%
Operating Margin	-15.77%
Pretax Margin	-14.12%
Profit Margin	-14.04%
EBITDA Margin	-10.96%
EBIT Margin	-15.77%
FCF Margin	3.21%

Dividends & Yields

TSX:CTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	4.44%
Shareholder Yield	4.44%
Earnings Yield	-25.39%
FCF Yield	5.80%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TSX:CTX has an Altman Z-Score of -0.91. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.91
Piotroski F-Score	n/a